Company: FVN
Filing Date: 2025-05-30
Form Type: S-4/A
Source: 0001829126-25-004067
Chunk: 162

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-05-30
Form: S-4/A
Chunk 162
---
’s shareholders may be afforded less protection than they otherwise would have under corporate governance listing standards applicable to U.S. domestic issuers.

<div align='center'>90</div>

Risks Related to New VIWO’s ordinary shares and Organizational Structure

The price of New VIWO’s ordinary shares likely will be volatile like the shares of other early-stage companies.

The stock markets in general and the markets for early-stage shares have experienced extreme volatility. The market for the ordinary shares of smaller companies such as ours is characterized by significant price volatility when compared to the shares of larger, more established companies that trade on a national securities exchange and have large public floats, and we expect that our share price will be more volatile than the shares of such larger, more established companies for the indefinite future.

In addition to the factors discussed in this “Risk Factors” section, price declines in our ordinary shares could also result from general market and economic conditions and a variety of other factors, including:

| ● | adverse actions taken by regulatory agencies with respect to our products;                                                                                                                                                                          |
| ● | announcements of technological innovations, patents or new products by our competitors;                                                                                                                                                             |
| ● | regulatory developments in the United States and foreign countries;                                                                                                                                                                                 |
| ● | any lawsuit involving us or our product candidates;                                                                                                                                                                                                 |
| ● | announcements concerning our competitors, or the industry in which we compete in general;                                                                                                                                                           |
| ● | developments concerning any strategic alliances or acquisitions we may enter into;                                                                                                                                                                  |
| ● | actual or anticipated variations in our operating results;                                                                                                                                                                                          |
| ● | changes in recommendations by securities analysts or lack of analyst coverage;                                                                                                                                                                      |
| ● | deviations in our operating results from the estimates of analysts;                                                                                                                                                                                 |
| ● | our inability, or the perception by investors that we will be unable, to continue to meet all applicable requirements for continued listing of our ordinary shares on the Nasdaq Capital Market, and the possible delisting of our ordinary shares; |
| ● | sales of our ordinary shares by our executive officers, directors and principal Shareholders or sales of substantial amounts of Ordinary Share; and                                                                                                 |
| ● | loss of any of our key management personnel.                                                                                                                                                                                                        |

In the past, following periods of volatility in the market price of a particular company’s securities, litigation has often been brought against that company. Any such lawsuit could consume resources and management time and attention, which could adversely affect our business.

If the Business Combination’s benefits do not meet the expectations of investors or securities analysts, the